The Structure/Function Relationship: What do we know? What would we like to know?
|
|
- Madeline Stephanie Collins
- 6 years ago
- Views:
Transcription
1 The Structure/Function Relationship: What do we know? What would we like to know? Brian R. Berridge, DVM, PhD, DACVP GlaxoSmithKline Research Triangle Park, NC
2 Outline A (very) brief overview of the structure and function of the cardiovascular system? What data are we integrating and where do we get it? Connecting the dots What do we still need to learn?
3 We know a fair bit about the cardiovascular system as an integration of form and function Blood vessels conduct blood to the heart itself as well as the rest of the body. Cardiomyocytes are contractile cells with immense energy needs Rhythmic waves of electrical activity ensure coordinated contraction of different regions of the heart. A muscular pump and its delivery system. Heart valves ensure unidirectional flow of blood.
4 We know something about what cardiovascular toxicity looks like! Nonclinical CV Toxicity Clinical CV Toxicity cardiomyocyte injury vascular injury Adverse CV events (Vioxx, Darvocet) Congestive Heart Failure (TZDs, TKIs) valvulopathy ultrastructural injury cellular biochemistry morphology Decreased EF (TKIs) Valvulopathy (Fen-Phen) cardiac mass function QT prolongation Non-QT arrhythmias QT prolongation/tdp risk BP HR contractility Increased blood pressure (Torcetrapib)
5 Possible Cardiac Adverse Effects of Drugs Primary functional effects ± morphological consequences Primary effect on cardiac structures ± secondary functional effects Effects on vascular motricity Adverse effects on cardiac function Direct effect on cardiac structure Exaggerated vasodilation and reflex activation of heart Arrhythmias ± conduction impairment Effect on contractile protein or Ca channels Myocardial degeneration Valvular proliferation e.g. QT prolongation Acute Chronic Myocardial necrosis Cardiac fibrosis Cardiac hypertrophy Decreased/impaired cardiac contractility Impairment of atrioventricular and/or arterial flows e.g. isoproterenol e.g. minoxidil e.g. doxorubicin e.g. anorexigenic drugs Exacerbation of pre-existing dz- 1 o, 2 o Not in the Hanton scheme Adapted from Hanton, G. Drugs R D 2007: 8(4):213
6 Possible Cardiac Adverse Effects of Drugs Primary functional effects ± morphological consequences Primary effect on cardiac structures ± secondary functional effects Effects on vascular motricity Adverse effects on cardiac function Direct effect on cardiac structure Exaggerated vasodilation and reflex activation of heart Arrhythmias ± conduction impairment Effect on contractile protein or Ca channels Myocardial degeneration Valvular proliferation e.g. QT prolongation Acute Chronic Myocardial necrosis Cardiac fibrosis Cardiac hypertrophy Decreased/impaired cardiac contractility Impairment of atrioventricular and/or arterial flows e.g. isoproterenol e.g. minoxidil e.g. doxorubicin e.g. anorexigenic drugs Exacerbation of pre-existing dz- 1 o, 2 o Not in the Hanton scheme Adapted from Hanton, G. Drugs R D 2007: 8(4):213
7 We know we generate a lot of relevant data in relatively sensitive ways?
8 In vitro screening for ion channel and receptor binding activity Prospective opportunity for identifying putative risks Retrospective opportunity to define pathogenesis/mechanism
9 In vivo studies Current paradigms in preclinical safety assessment Acute/Single Dose Safety Pharmacology Studies Functional endpoints Multiple species In vitro/ex vivo Rodents Non-Rodents Early Development CV Fxn FTIH-enabling GLP CV Study Patch clamp ion channel assays Rabbit wedge assay Translatable biomarkers Telemetered rat Heart rate ECG (quantitative) No QT Blood pressure ± surrogate measures of contractility- LVP, QA Telemetered dog or monkey Heart rate ECG (quantitative) Blood pressure ± surrogate measures of contractility- LVP, QA
10 Current paradigms in preclinical safety assessment In Vivo Repeat-Dose General Toxicity Studies Rodents Multiple species Non-Rodents 4 days Repeat-dose studies of increasing length at super-pharmacologic 2 years doses Morphologic endpoints Blood/urine biomarkers Functional endpoints Organ weight Gross Microscopic - light microscopy - ultrastructure Serum chemistry Hematology Hemostasis Urinanalysis Heart rate ECG (qualitative) Translatable biomarkers * Repeat dose studies biased toward morphologic endpoints
11 Morphologic Evaluation- Gross to Microscopic Gross examination of the intact rodent heart Light microscopy of myocardium Ultrastructure of myocardium Evaluation of atrioventricular valve of opened non-rodent (dog) heart Light microscopy of atrioventricular valve
12 Standard clinical pathology endpoints in repeat-dose toxicity studies Serum chemistry Biomarkers of hepatobiliary injury- ALT, AST, Tbili, ALP, GGT Biomarkers of muscle injury- CK, AST, Potassium Biomarkers of renal injury- BUN, Cr, Urine Sp Gr, Urine Total Protein Biomarkers of metabolic health- glucose, triglycerides, cholesterol, electrolytes, total protein, albumin, globulins Biomarkers of calcium-phosphorus balance calcium, inorganic phosphorus Hematology Biomarkers of inflammation, hematologic dyscrasia, hematopoiesis CBC, reticulocyte count, blood smear review Biomarkers of coagulation- PT, APTT, fibrinogen, platelet count Urinanalysis Biomarkers of renal health, metabolic health - ph, protein, glucose, blood, bilirubin, ketones, urobilinogen, urine sediment, urine specific gravity, renal electrolytes Endpoints with particular relevance to CV injury Compliments of A. Eric Schultze
13 Novel CV Biomarker Interests Cardiac troponins Natriuretic peptides H-FABP Novel contexts of use for troponins or natriuretic peptides Imaging mirnas
14 We know what we re looking for! Changes in serum chemistry Increases in ctn, NTproANP/BNP, CK, K+ Altered coagulation parameters Changes in function Inotropy, chronotropy, rhythmicity Changes in heart mass with our without proportional changes in chamber volumes Cellular injury Vacuolation Degeneration Necrosis Apoptosis Hypertrophy Myocardial injury Hemorrhage Inflammation Fibrosis Valvular injury Vascular injury *Important to recognize that the heart, like many target organs, has a finite number of ways to respond to altered physiology or noxious stimuli.
15 And what it looks like! 4 mg/kg s.c. in F344 rats 2-4 hr 24 hr 48 hr Temporal pathogenesis of isoproterenolinduced injury in the rat heart 2 weeks
16 Vascular responses to injury Vasoconstrictor/hypertension injury Medial hypertrophy/hyperplasia Periarterial fibrosis Fibrinoid necrosis Compliments of H. Thomas
17 We know what to do with the data when we get it: Integrated Interpretation of Histopathology Data Light microscopy Vascular injury Myocardial injury Valvulopathy Is there a correlative change in blood pressure? Is the injury reversible or irreversible (e.g. necrosis, fibrosis) Generally not monitorable = Dose and development limiting NO YES reversible irreversible Possible direct vasculotoxin and more difficult development challenge Possible translational biomarker or screening parameter NO May be dose &/or development limiting Is there a correlative functional change? YES Translational biomarkers Is there a correlative increase in ctni? NO Re-examine time of sampling YES Reporting translational biomarker Is the molecule an ergot alkaloid or have ALK 5 inhibitory activity? SAR screen Monitorability and exposure margins significantly impact progression opportunity!
18 We know functional changes can lead to structural injuries: Minoxidil as a model cardiovascular toxicant in rats Effect of Minoxidil on Arterial Blood Pressure and Heart Rate in Conscious Rat Minoxidil is a vasodilating K+ channel blocker 7d repeat-dose rat CV study Mean absolute (relative to BW) heart weight Gp % (+3.6%) Gp % (+13.4%) Gp % (+6.7%) Multifocal myocardial necrosis Single dose rat CV study Arterial injury in the mesentery Minoxidil (mg/kg) MAP HR 3 Maximal decrease of 22 mmhg Effect last ~22 h Maximal increase of 70 beats/min Effect last ~6 h 30 Maximal decrease of 23 mmhg Effect last ~24 h Maximal increase of 181 beats/min Effect last ~24 h 100 Maximal decrease of 33 mmhg Effect last ~24 h Maximal increase of 138 beats/min Effect last ~24 h
19 PDE4 inhibitors can do it too! Subendocardial necrosis Vascular injury *no HW reported
20 What I would like to know? Structure Every Study Function Logistical challenges Technological challenges How do we get these relationships from the right studies?
21 We need to understand the complexity of our target patients better! Attributes of a diabetic patient population Concurrent medications Ischemic heart dz Stroke Heart failure Renal disease Hyperglycemia Hypertension Dyslipidemia How do we model diabetic patients preclinically? Baseline characteristics of patients with diabetes studied in the RECORD trial. Lancet 373: , 2009
22 We need to know how to better model our target patients!
23 Drug-induced vascular injury- place for a significant safety pharmacology contribution??
24 Gap = there are no biomarkers of vasoactivity on these lists!
25 Thank you! Questions?
Patient Susceptibilities in Preclinical Drug Safety Assessment
Patient Susceptibilities in Preclinical Drug Safety Assessment B. R. Berridge GlaxoSmithKline ILAR Roundtable October, 2017 Animal studies represent an apical preclinical modeling system in drug development
More informationHESI Technical Committee on Cardiovascular Safety: Advancing the clinical relevance of preclinical assessments
HESI Technical Committee on Cardiovascular Safety: Advancing the clinical relevance of preclinical assessments Brian R. Berridge, DVM, PhD, DACVP Committee Co-Chair ILSI Health and Environmental Sciences
More informationRapid Laboratories In House Tests
Electrolytes CL CL (CHLORIDE) Electrolytes CO2 CO2 (BICARBONATE) Electrolytes K K (POTASSIUM) Electrolytes NA NA (SODIUM) Basic Metabolic Panel (BMP) GLU GLU (GLUCOSE) Basic Metabolic Panel (BMP) CA CA
More informationIn the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension
In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial
More informationPresented by: Dr. Giuseppe Molinaro Dr. Davide De Biase
Presented by: Dr. Giuseppe Molinaro Dr. Davide De Biase Dog Spayed Female LABRADOR RETRIEVER 3 Years old VACCINATIONS ANTIPARASITIC COMMERCIAL DIET VOMITING FOR A MONTH DULLNESS WEIGHT LOSS INAPPETANCE
More informationREFERENCE INTERVALS. Units Canine Feline Bovine Equine Porcine Ovine
REFERENCE INTERVALS Biochemistry Units Canine Feline Bovine Equine Porcine Ovine Sodium mmol/l 144-151 149-156 135-151 135-148 140-150 143-151 Potassium mmol/l 3.9-5.3 3.3-5.2 3.9-5.9 3.0-5.0 4.7-7.1 4.6-7.0
More informationSMALL ANIMAL SOFT TISSUE CASE-BASED EXAMINATION
SMALL ANIMAL SOFT TISSUE CASE-BASED EXAMINATION CASE-BASED EXAMINATION INSTRUCTIONS The case-based examination measures surgical principles in case management prior to, during, and after surgery. Information
More informationHamilton Regional Laboratory Medicine Program
Created: April 2002 of Review: February 2004 of Review: June 2006 of Review: July 2007, St. Joseph s Healthcare went live with Meditech as of June18, 2007. of Review: August 2009 of Review: December 2011;
More informationBIOL 219 Spring Chapters 14&15 Cardiovascular System
1 BIOL 219 Spring 2013 Chapters 14&15 Cardiovascular System Outline: Components of the CV system Heart anatomy Layers of the heart wall Pericardium Heart chambers, valves, blood vessels, septum Atrioventricular
More informationHamilton Regional Laboratory Medicine Program
Created: April 2002 of Review: February 2004 of Review: June 2006 of Review: July 2007, St. Joseph s Healthcare went live with Meditech as of June18, 2007. of Review: August 2009 of Review: December 2011;
More informationCirculation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output.
Circulation Blood Pressure and Antihypertensive Medications Two systems Pulmonary (low pressure) Systemic (high pressure) Aorta 120 mmhg Large arteries 110 mmhg Arterioles 40 mmhg Arteriolar capillaries
More informationThe goal of these lectures is to discuss
Cardiovascular (#2) The goal of these lectures is to discuss basic physiology of the cardiovascular system (heart, vessels, blood pressure, control, hemostasis). This second lecture will discuss blood
More informationEpic Labs Orderable As STAT PRIORITY As of 06/22/2016
ABG+HB(CORDARTERIAL) - BABY A ABG+HB(CORD ARTERIAL)- BABY B ABG+HB(CORD ARTERIAL)- BABY C ACETAMINOPHEN LEVEL ALANINE AMINOTRANSFERASE (ALT) ALBUMIN, FLUID ALBUMIN, PLEURAL FLUID ALBUMIN, SYNOVIAL FLUID
More informationInspector's Accreditation Unit Activity Menu
01/12/20XX 15:58:57 Laboratory Accreditation Program Page 1 of 9 CHEMISTRY 1501 ALT, serum/plasma 1502 Albumin, serum/plasma 1504 Alkaline phosphatase, serum/plasma 1506 Amylase, serum/plasma 1508 Bilirubin,
More information1.) 3 yr old FS Siamese cat: 3 day history of lethargy, anorexia. Dyspneic, thin, febrile.
1.) 3 yr old FS Siamese cat: 3 day history of lethargy, anorexia. Dyspneic, thin, febrile. NUCLEATED CELLS 19.5 High 4.0-14.0 x 10^3/ul METAMYELOCYTES 9 % 1.8 High 0.0-0.0 x 10^3/ul BAND NEUTROPHILS 61
More informationUTHEALTH HOUSTON CCTS BIOBANK VARIABLE LIST
Please check the requested variables:, and/or. Obtained at Initial Hospital Recruitment Demographics: Age Gender Marital Status Ethnicity Race Height (inches) Weight (pounds) Main language spoken Socioeconomic
More informationSMALL ANIMAL SOFT TISSUE CASE- BASED EXAMINATION
SMALL ANIMAL SOFT TISSUE CASE- BASED EXAMINATION CASE-BASED EXAMINATION INSTRUCTIONS The case-based examination measures surgical principles in case management prior to, during, and after surgery. Information
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Spire Portsmouth Hospital Bartons Road Havant PO9 5NP United Kingdom Contact: Natalie Peck E-Mail: natalie.peck@spirehealthcare.com Website:
More informationChapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure
Chapter 10 Congestive Heart Failure Learning Objectives Explain concept of polypharmacy in treatment of congestive heart failure Explain function of diuretics Learning Objectives Discuss drugs used for
More informationPOSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO
POSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO Selection Examination for Enrolment to the in-service Training Programme in Postgraduate Certificate in Basic Laboratory Sciences leading to the
More informationTables of Normal Values (As of February 2005)
Tables of Normal Values (As of February 2005) Note: Values and units of measurement listed in these Tables are derived from several resources. Substantial variation exists in the ranges quoted as normal
More informationHeart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea)
Pharmacology I. Definitions A. Heart Failure (HF) Heart Failure Ezra Levy, Pharm.D. HF Results when one or both ventricles are unable to pump sufficient blood to meet the body s needs There are 2 types
More informationThe Circulatory System. The Heart, Blood Vessels, Blood Types
The Circulatory System The Heart, Blood Vessels, Blood Types The Closed Circulatory System Humans have a closed circulatory system, typical of all vertebrates, in which blood is confined to vessels and
More informationAustralian and New Zealand College of Veterinary Scientists. Membership Examination. Veterinary Pathology Paper 1
Australian and New Zealand College of Veterinary Scientists Membership Examination June 2014 Veterinary Pathology Paper 1 Perusal time: Fifteen (15) minutes Time allowed: Two (2) hours after perusal Answer
More informationBlood and Circulation Module
Blood and Circulation Module 1 Module coordinator Prof. NS Kalupahana Module code CONCEPT Objectives 3/1 3/2 Students should be able to understand the Overview clinical relevance to structure and function
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Chen CL, Lin GA, Bardach NS, et al. Preoperative medical testing
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Spire Portsmouth Hospital Bartons Road Havant PO9 5NP United Kingdom Contact: Natalie Peck E-Mail: natalie.peck@spirehealthcare.com Website:
More information*Generating blood pressure *Routing blood: separates. *Ensuring one-way blood. *Regulating blood supply *Changes in contraction
*Generating blood pressure *Routing blood: separates pulmonary and systemic circulations *Ensuring one-way blood flow: valves *Regulating blood supply *Changes in contraction rate and force match blood
More informationBurak DiK 1, Emre BAHCIVAN 1,2, Hatice ESER 1,3, Kamil UNEY 1
Burak DiK 1, Emre BAHCIVAN 1,2, Hatice ESER 1,3, Kamil UNEY 1 1 Selcuk University Faculty of Veterinary Medicine, Pharmacology and Toxicology Department, Konya, TURKEY 2 Kafkas University Faculty of Veterinary
More informationIn Vivo Animal Models of Heart Disease. Why Animal Models of Disease? Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison
In Vivo Animal Models of Heart Disease Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison Why Animal Models of Disease? Heart Failure (HF) Leading cause of morbidity and mortality
More informationCiPA, Pre-clinical Testing. Derek Leishman PhD DSP & ICH S7B
CiPA, Pre-clinical Testing Derek Leishman PhD DSP & ICH S7B Outline Introduction Scenarios Conclusion Expressing an opinion What is not covered? Analysis/critique of the components too little time to try
More informationGilles HANTON, BVSc, DVM, DABT, ERT GH Toxconsulting Brussels, Belgium
Gilles HANTON, BVSc, DVM, DABT, ERT GH Toxconsulting Brussels, Belgium What is echocardiography (EC) Ultrasounds (US) are emitted by a transducer Reflection of US on tissues depends on their physical properties
More informationTrial to Reduce. Aranesp* Therapy. Cardiovascular Events with
Trial to Reduce Cardiovascular Events with Aranesp* Therapy John J.V. McMurray, Hajime Uno, Petr Jarolim, Akshay S. Desai, Dick de Zeeuw, Kai-Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis,
More informationDysrhythmias. Dysrythmias & Anti-Dysrhythmics. EKG Parameters. Dysrhythmias. Components of an ECG Wave. Dysrhythmias
Dysrhythmias Dysrythmias & Anti-Dysrhythmics Rhythm bad in the heart: Whitewater rafting Electrical impulses coordinate heart Reduction in Cardiac Output PEA Asystole Components of an ECG Wave EKG Parameters
More informationCOMPANY OR UNIVERSITY
CONTRIBUTOR NAME Daniel Heinrich, DVM CONTRIBUTOR EMAIL dheinric@umn.edu COAUTHORS Jed Overmann, DVM, DACVP; Davis Seelig DVM, PhD, DACVP & Matthew Sturos, DVM COMPANY OR UNIVERSITY University of Minnesota
More informationOnline catalog
This catalog contains information about tests performed at Green Clinic Laboratory. For samples to be sent to Quest Diagnostics or any other reference lab please contact the Green Clinic Laboratory (318-251-6378)
More informationBASIC METABOLIC PANEL
Update 2/12/2018 BASIC METABOLIC PANEL CPT 80048 Stability: 3 days at 15-25 C; 7 days at 2-8 C; > 7 days at -70 C Colorimetric Assay, Rate reaction, ISE Components: BUN, Calcium, Chloride, CO2, Creatinine,
More informationChallenging Issues in Cardiac Biomarker interpretation. F. Nikaeen. MD interventional Cardiologist
Challenging Issues in Cardiac Biomarker interpretation F. Nikaeen. MD interventional Cardiologist Biomarkers Types of Troponin Troponin C Binds calcium Troponin I Binds actin Troponin T Binds tropomyosin
More informationCardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009
Cardiovascular disease, studies at the cellular and molecular level Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009 Content Introduction The number 1 killer in America Some statistics
More informationHYPEREMIA AND CONGESTION
HYPEREMIA AND CONGESTION Learning Objectives Define congestion and hyperemia Differentiate between the two with regard to: Mechanisms / underlying causes Appearance (gross and histologic) Effects Differentiate
More informationThe Cardiovascular System
Chapter 18 Part A The Cardiovascular System 1/19/16 1 Annie Leibovitz/Contact Press Images Similarities of Cardiac and Skeletal Muscle RMP Ion concentration Deploarization Action Potential Repolarization
More informationSpecimen Collection Requirements
The following is a job aid listing the specimen collection requirements for laboratory testing at Colchester East Hants Health Center. Specimens must be accompanied by the Patient Information Form G09.
More informationChapter 10 Worksheet Blood Pressure and Antithrombotic Agents
Complete the following. 1. A layer of cells lines each vessel in the vascular system. This layer is a passive barrier that keeps cells and proteins from going into tissues; it also contains substances
More informationSpecimen Collection Requirements
The following is a job aid listing the specimen collection requirements for laboratory testing at Colchester East Hants Health Center. Specimens must be accompanied by the Patient Information Form G09.
More informationPatient Encounters in the Primary Care Setting
Patient Encounters in the Primary Care Setting Carmine D Amico, D.O. Clinical Cases Overview Learning objectives Clinical case presentations Questions for audience participation 1 Clinical Cases Learning
More informationBiomarkers of Cardiovascular diseases. By Dr. Gouse Mohiddin Shaik
Biomarkers of Cardiovascular diseases By Dr. Gouse Mohiddin Shaik In this section we will discuss Introduction Types of CVD CVD biomarkers Future CVD biomarkers Introduction CVD is the one of the leading
More informationCollin County Community College
Collin County Community College BIOL. 2402 Anatomy & Physiology WEEK 5 The Heart 1 The Heart Beat and the EKG 2 1 The Heart Beat and the EKG P-wave = Atrial depolarization QRS-wave = Ventricular depolarization
More informationSydPath Reference Intervals for Clinical Trials (Contract Pathology Unit) Unauthorised Copy
HAEMATOLOGY APTT 1 150 M 25 35 sec APTT 1 150 F 25 35 sec Basophils Cord 2 weeks M 0.0 0.4 10^9/L Basophils Cord 2 weeks F 0.0 0.4 10^9/L Basophils 2 wks 3 mths M 0.0 0.2 10^9/L Basophils 2 wks 3 mths
More informationAgents that inhibit the BSEP and mitochondrial function what do we know? Prepared by Michael D. Aleo, Ph.D. Groton, Investigative Toxicology
Agents that inhibit the BSEP and mitochondrial function what do we know? Prepared by Michael D. Aleo, Ph.D. Groton, Investigative Toxicology Declarations Nonclinical studies All procedures performed on
More informationDiagnosis and Management of Acute Myocardial Infarction
Diagnosis and Management of Acute Myocardial Infarction Acute Myocardial Infarction (AMI) occurs as a result of prolonged myocardial ischemia Atherosclerosis leads to endothelial rupture or erosion that
More informationPathophysiology of Cardiovascular System. Dr. Hemn Hassan Othman, PhD
Pathophysiology of Cardiovascular System Dr. Hemn Hassan Othman, PhD hemn.othman@univsul.edu.iq What is the circulatory system? The circulatory system carries blood and dissolved substances to and from
More informationCardiac Output MCQ. Professor of Cardiovascular Physiology. Cairo University 2007
Cardiac Output MCQ Abdel Moniem Ibrahim Ahmed, MD Professor of Cardiovascular Physiology Cairo University 2007 90- Guided by Ohm's law when : a- Cardiac output = 5.6 L/min. b- Systolic and diastolic BP
More informationMEDICAL HISTORY. 23-Jan-2018 to 23-Jan VCA Miller-Robertson Animal Hospital 8807 Melrose Ave, Los Angeles, CA (310)
8807 Melrose Ave, Los Angeles, CA 90069 (310) 657-7050 MEDICAL HISTORY 23-Jan-2018 to 23-Jan-2018 Client Linnea Engdahl (1810) C: Linnea: (310) 351-9547 Patient Abby (6487) Canine Mixed Breed 3y (22-Jan-2015)
More informationTo be used for the ease of test requisitioning on select patients only; all components may be ordered separately
Panels Section To be used for the ease of test requisitioning on select patients only; all components may be ordered separately ANEMIA 1(I) PANEL (NMC & UMMC) ANEM1(I) S 8.0 ml Large Tests included are:
More informationChemistry Reference Ranges and Critical Values
Alanine Aminotransferase (ALT, SGPT) 3-9 years 9-18 years 1-9 years 9-18 years 10-25 U/L 10-35 U/L 10-30 U/L 10-25 U/L 10-30 U/L 10-35 U/L 10-25 U/L 10-35 U/L 10-25 U/L 10-20 U/L 10-35 U/L Albumin 0-6
More informationChemistry Reference Ranges and Critical Values
Alanine Aminotransferase (ALT, SGPT) 3-9 years 9-18 years 1-9 years 9-18 years 10-30 U/L 10-30 U/L 10-20 U/L Albumin 0-6 days 6 days - 37 months 37 months - 7 years 7-20 years 2.6-3.6 g/dl 3.4-4.2 g/dl
More informationIschemic heart disease
Ischemic heart disease Introduction In > 90% of cases: the cause is: reduced coronary blood flow secondary to: obstructive atherosclerotic vascular disease so most of the time it is called: coronary artery
More informationCollin County Community College. ! BIOL Anatomy & Physiology! WEEK 5. The Heart
Collin County Community College! BIOL. 2402 Anatomy & Physiology! WEEK 5 The Heart 1 (1578-1657) A groundbreaking work in the history of medicine, English physician William Harvey s Anatomical Essay on
More informationM2 TEACHING UNDERSTANDING PHARMACOLOGY
M2 TEACHING UNDERSTANDING PHARMACOLOGY USING CVS SYSTEM AS AN EXAMPLE NIGEL FONG 2 JAN 2014 TODAY S OBJECTIVE Pharmacology often seems like an endless list of mechanisms and side effects to memorize. To
More informationFUNDAMENTALS OF HEMODYNAMICS, VASOACTIVE DRUGS AND IABP IN THE FAILING HEART
FUNDAMENTALS OF HEMODYNAMICS, VASOACTIVE DRUGS AND IABP IN THE FAILING HEART CINDY BITHER, MSN, ANP, ANP, AACC, CHFN CHIEF NP, ADV HF PROGRAM MEDSTAR WASHINGTON HOSPITAL CENTER CONFLICTS OF INTEREST NONE
More informationCardiovascular health & Health Promotion HH2602 & HH5607
Cardiovascular health & Health Promotion HH2602 & HH5607 Lecture 2: Microscopic Structure and Function of the Heart 2pm 28-02-17 ESGW Teaching Aims To introduce you to the microstructure of heart muscle.
More informationSPECTRA EAST, INC. Rockleigh, NJ
A2LA has accredited SPECTRA EAST, INC. Rockleigh, NJ for technical competence in the field of Medical Testing This laboratory is accredited in accordance with the recognized International Standard ISO/IEC
More informationhttp://noodlemaz.wordpress.com/category/science/cancer/ Outline Introduction Serious nature of Cardiovascular Disease (CVD) How to prevent CVD? The disease process Damage and plaque development Current
More informationNon-Ischemic Causes of Troponin Elevation: Getting It Right. March 28, 2015
Non-Ischemic Causes of Troponin Elevation: Getting It Right March 28, 2015 WHY discuss this...? Misconceptions about meaning of elevated troponin Validation of troponin when utilized properly Prognostic
More informationBIOCHEMICAL INVESTIGATIONS IN THE DIAGNOSTICS OF CARDIOVASCULAR DISORDERS. As. MARUSHCHAK M.I.
BIOCHEMICAL INVESTIGATIONS IN THE DIAGNOSTICS OF CARDIOVASCULAR DISORDERS As. MARUSHCHAK M.I. Heart attack symptoms Acute MI Measurement of cardiac enzyme levels Measure cardiac enzyme levels at regular
More informationQuestionnaire. Traceability in EQA. Traceability
Questionnaire in EQA QUESTIONNAIRE ON TRACEABILITY QUESTIONNAIRE ON TRACEABILITY GENERAL INFORMATION Name EQA organisation Country Specify the total number of measurands in the schemes of your EQA organisation
More informationThe Anatomy and Physiology of the Circulatory System
CHAPTER 5 The Anatomy and Physiology of the Circulatory System The Circulatory System Blood Heart Vascular System THE BLOOD Formed Elements of Blood Table 5-1 Cell Type Erythrocytes (Red Blood Cells, RBCs)
More informationBiomarkers of myocardial infarction. Dr. Mamoun Ahram Cardiovascular system, 2013
Biomarkers of myocardial infarction Dr. Mamoun Ahram Cardiovascular system, 2013 References This lecture Hand-outs Acute Myocardial Infarction A rapid development of myocardial necrosis caused by prolonged
More informationChapter 9, Part 2. Cardiocirculatory Adjustments to Exercise
Chapter 9, Part 2 Cardiocirculatory Adjustments to Exercise Electrical Activity of the Heart Contraction of the heart depends on electrical stimulation of the myocardium Impulse is initiated in the right
More informationELECTROCARDIOGRAPHY (ECG)
ELECTROCARDIOGRAPHY (ECG) The heart is a muscular organ, which pumps blood through the blood vessels of the circulatory system. Blood provides the body with oxygen and nutrients, as well as assists in
More information2015 Miniboard Exam Candidate # Clinical Pathology
2015 Miniboard Exam Candidate # Clinical Pathology 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 1 2015 Miniboard Exam Clinical Pathology 1. An aspirate from
More informationCardiac Pathophysiology
Cardiac Pathophysiology Evaluation Components Medical history Physical examination Routine laboratory tests Optional tests Medical History Duration and classification of hypertension. Patient history of
More informationPerspectives on Evaluating and Managing Cardiovascular Safety Risk for Anticancer Drugs
Perspectives on Evaluating and Managing Cardiovascular Safety Risk for Anticancer Drugs DCTD/DTP/TPB Myrtle Davis, DVM, Ph.D. Chief, Toxicology and Pharmacology Branch Division of Cancer Treatment and
More informationAdams Memorial Hospital Decatur, Indiana EXPLANATION OF LABORATORY TESTS
Adams Memorial Hospital Decatur, Indiana EXPLANATION OF LABORATORY TESTS Your health is important to us! The test descriptions listed below are for educational purposes only. Laboratory test interpretation
More informationCardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century October 4, 2010
Cardiovascular disease, studies at the cellular and molecular level Linda Lowe Krentz Bioscience in the 21 st Century October 4, 2010 Content Introduction The number 1 killer in America Some statistics
More informationISO 15189:2012 Internationally-Recognized Accredited Laboratory. SPECTRA EAST, INC. Rockleigh, NJ
ISO 15189:2012 Internationally-Recognized Accredited Laboratory A2LA has accredited SPECTRA EAST, INC. Rockleigh, NJ for technical competence in the field of Clinical Testing This laboratory is accredited
More informationBiomarkers in cardiovascular disease. Felix J. Rogers, DO, FACOI April 29, 2018
Biomarkers in cardiovascular disease Felix J. Rogers, DO, FACOI April 29, 2018 Biomarkers NIH: A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biological
More informationCellular responses to stress
Cellular responses to stress (Adaptations, injury and death) (2 of 5) Most injurious stimuli are grouped into: Oxygen deprivation Chemical agents Infectious agents Immunologic reactions Genetic factors
More informationChapter 12: Cardiovascular Physiology System Overview
Chapter 12: Cardiovascular Physiology System Overview Components of the cardiovascular system: Heart Vascular system Blood Figure 12-1 Plasma includes water, ions, proteins, nutrients, hormones, wastes,
More informationFOCUS ON CARDIOVASCULAR DISEASE
The Consequences of Vitamin D Deficiency: FOCUS ON CARDIOVASCULAR DISEASE Vitamin D deficiency is a global health problem. With all the medical advances of the century, vitamin D deficiency is still epidemic.
More informationMyocardial Infarction
Myocardial Infarction MI = heart attack Defined as necrosis of heart muscle resulting from ischemia. A very significant cause of death worldwide. of these deaths, 33% -50% die before they can reach the
More informationChapter 13 The Cardiovascular System: Cardiac Function
Chapter 13 The Cardiovascular System: Cardiac Function Overview of the Cardiovascular System The Path of Blood Flow through the Heart and Vasculature Anatomy of the Heart Electrical Activity of the Heart
More informationStructure and organization of blood vessels
The cardiovascular system Structure of the heart The cardiac cycle Structure and organization of blood vessels What is the cardiovascular system? The heart is a double pump heart arteries arterioles veins
More informationMultiple Choice Questions and Answers
Barger both02.tex V3-07/08/2015 7:05 P.M. Page 1 Multiple Choice Questions and Answers Chapter 1 Getting Started with Clinical Pathology 1. Which component of the microscope should be adjusted when evaluating
More informationCardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
More informationUse of Minipigs in Juvenile Toxicity Studies. Melissa Beck, PhD
Use of Minipigs in Juvenile Toxicity Studies Melissa Beck, PhD Introduction The potential for juvenile toxicity of pharmaceuticals in humans is frequently evaluated in animal models, and is often assessed
More informationHYPERCALCEMIC GOLDEN RETRIEVER
Presenter: Laura Martínez 1, 2 HYPERCALCEMIC GOLDEN RETRIEVER Contributors: Laia Solano-Gallego 2, Josep Pastor 2, Alberto J. Marco 3, María Cuvertoret-Sanz 3, Rosa Novellas 1,2, Anna Vila 1, 2, Xavier
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST Is there a mortality risk associated with aspirin use in heart failure? Results from a large community based cohort Margaret Bermingham, Mary-Kate Shanahan, Saki Miwa,
More informationCirculatory System Function Move circulatory fluid (blood) around body Gas Transport Nutrient Transport Excretory Product Transport
Lecture 37 Introduction to Circulation BY DR QAZI IMTIAZ RASOOL OBJECTIVES Functions of the Heart Generating blood pressure Routing blood: separates pulmonary and systemic circulations Ensuring one-way
More informationProceedings of the 36th World Small Animal Veterinary Congress WSAVA
www.ivis.org Proceedings of the 36th World Small Animal Veterinary Congress WSAVA Oct. 14-17, 2011 Jeju, Korea Next Congress: Reprinted in IVIS with the permission of WSAVA http://www.ivis.org 14(Fri)
More informationCardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.
Complete the following. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate. 2. drugs affect the force of contraction and can be either positive or negative. 3.
More informationHeart Failure in Women: Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre
Heart Failure in Women: More than EF? Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre Overview Review pathophysiology as it relates to diagnosis and management Rational approach to workup:
More informationPrinciples of Anatomy and Physiology
Principles of Anatomy and Physiology 14 th Edition CHAPTER 20 The Cardiovascular System: The Heart Introduction The purpose of the chapter is to: 1. Learn about the components of the cardiovascular system
More informationDisclosures (2013 to the present)
What level and types of CV safety data acquisition should be considered to sufficiently characterize a drug s benefit/risk assessment by the end of Phase 3 development? Cardiac Safety Research Consortium
More information10 Essential Blood Tests PART 1
Presents 10 Essential Blood Tests PART 1 The Blood Chemistry Webinars With DR. DICKEN WEATHERBY Creator of the Blood Chemistry Software Essential Blood Test #1: Basic Chem Screen and CBC http://bloodchemsoftware.com
More informationVasoactive Medications. Matthew J. Korobey Pharm.D., BCCCP Critical Care Clinical Specialist Mercy St. Louis
Vasoactive Medications Matthew J. Korobey Pharm.D., BCCCP Critical Care Clinical Specialist Mercy St. Louis Objectives List components of physiology involved in blood pressure Review terminology related
More informationCardiovascular disease and diabetes Vascular harmony
Cardiovascular disease and diabetes 2018 Vascular harmony Robert Chilton Professor of Medicine University of Texas Health Science Center Director of Cardiac Catheterization labs Director of clinical proteomics
More informationCardiorenal and Renocardiac Syndrome
And Renocardiac Syndrome A Vicious Cycle Cardiorenal and Renocardiac Syndrome Type 1 (acute) Acute HF results in acute kidney injury Type 2 Chronic cardiac dysfunction (eg, chronic HF) causes progressive
More informationAtrioventricular Valve Endocardiosis Basics
Atrioventricular Valve Endocardiosis Basics OVERVIEW Atrioventricular valve refers to the heart valves between the top chamber (known as the atrium ) and the bottom chamber (known as the ventricle ) of
More informationEDUCATIONAL COMMENTARY CARDIAC FUNCTION: BIOCHEMICAL MARKERS UPDATE
EDUCATIONAL COMMENTARY CARDIAC FUNCTION: BIOCHEMICAL MARKERS UPDATE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE
More information